Funding for this research was provided by:
National Health and Medical Research Council (1010494, 1048216, 1087407, 1107828, 1127156, 1163933)
Sir Charles Gairdner Osborne Park Health Care Group Research Advisory Committee (2016-17/017)
Raine Medical Research Foundation (Priming Grant)
Received: 16 October 2019
Accepted: 11 March 2020
First Online: 26 March 2020
Ethics approval and consent to participate
: Written informed consent was obtained from all participants in the osteoclast eQTL cohort, and the study was approved by the Sir Charles Gairdner and Osborne Park Health Care Group Human Research Ethics Committee. All mouse work was performed using methods approved by the University of Western Australia Animal Ethics Committee (RA/3/100/779). The experimental methods used in this study comply with the Helsinki Declaration.
: Not applicable.
: The authors declare that they have no competing interests.